We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$862M
AUM Growth
+$65.8M
Cap. Flow
-$3.49M
Cap. Flow %
-0.4%
Top 10 Hldgs %
34.36%
Holding
146
New
6
Increased
58
Reduced
58
Closed
5

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$2.36M
2
NVDA icon
NVIDIA
NVDA
+$1.76M
3
LLY icon
Eli Lilly
LLY
+$1.55M
4
CRM icon
Salesforce
CRM
+$1.32M
5
XOM icon
ExxonMobil
XOM
+$1.16M

Top Sells

Rank Stock Value
1
SWKS icon
Skyworks Solutions
SWKS
+$2.76M
2
PFE icon
Pfizer
PFE
+$2.61M
3
CNI icon
Canadian National Railway
CNI
+$1.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.28M
5
BHP icon
BHP
BHP
+$992K

Sector Composition

Rank Sector Weight
1 Technology 18.29%
2 Financials 13.79%
3 Healthcare 13.62%
4 Consumer Discretionary 11.53%
5 Communication Services 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
26
Accenture
ACN
$101B
$11.4M 1.32%
32,386
-90
-0.3% -$29K
WMT icon
27
Walmart Inc
WMT
$881B
$11M 1.27%
209,097
-627
-0.3% -$33.2K
EOG icon
28
EOG Resources
EOG
$77.6B
$11M 1.27%
90,647
+1,422
+2% +$177K
PAYX icon
29
Paychex
PAYX
$41.9B
$10.2M 1.18%
85,696
+4,962
+6% +$588K
CNI icon
30
Canadian National Railway
CNI
$76.1B
$10.2M 1.18%
80,987
-15,918
-16% -$1.8M
GPN icon
31
Global Payments
GPN
$23.6B
$9.15M 1.06%
72,022
+2,040
+3% +$236K
ABT icon
32
Abbott
ABT
$185B
$8.78M 1.02%
79,798
-2,089
-3% -$209K
SLB icon
33
SLB Ltd
SLB
$73.2B
$8.77M 1.02%
168,505
+9,979
+6% +$542K
STE icon
34
Steris
STE
$22.7B
$8.68M 1.01%
39,478
-1,421
-3% -$301K
KMI icon
35
Kinder Morgan
KMI
$69.9B
$8.58M 1%
486,483
+17,431
+4% +$297K
EXP icon
36
Eagle Materials
EXP
$6.59B
$7.93M 0.92%
39,095
+1,561
+4% +$274K
NKE icon
37
Nike
NKE
$63.3B
$7.82M 0.91%
71,986
+1,157
+2% +$124K
MA icon
38
Mastercard
MA
$500B
$7.74M 0.9%
18,141
+5,869
+48% +$2.36M
URI icon
39
United Rentals
URI
$69.5B
$7.73M 0.9%
13,474
-707
-5% -$333K
FTNT icon
40
Fortinet
FTNT
$120B
$7.36M 0.85%
125,667
+245
+0.2% +$13.5K
DEO icon
41
Diageo
DEO
$49.2B
$6.94M 0.81%
47,668
-2,709
-5% -$400K
IQV icon
42
IQVIA
IQV
$38.4B
$6.76M 0.78%
29,205
-463
-2% -$95.1K
CAH icon
43
Cardinal Health
CAH
$55.2B
$6.74M 0.78%
66,837
+386
+0.6% +$38.3K
BHP icon
44
BHP
BHP
$212B
$6.6M 0.77%
96,620
-16,430
-15% -$992K
CTVA icon
45
Corteva
CTVA
$50.9B
$6.37M 0.74%
132,999
-15,042
-10% -$717K
CTAS icon
46
Cintas
CTAS
$81.6B
$6.26M 0.73%
41,572
-260
-0.6% -$34.8K
DIS icon
47
Walt Disney
DIS
$170B
$6.22M 0.72%
68,837
+4,135
+6% +$365K
PFE icon
48
Pfizer
PFE
$143B
$6.18M 0.72%
214,808
-86,499
-29% -$2.61M
LLY icon
49
Eli Lilly
LLY
$1,000B
$6.09M 0.71%
10,442
+2,663
+34% +$1.55M
PLD icon
50
Prologis
PLD
$135B
$5.9M 0.68%
44,230
-740
-2% -$84K

Similar funds

Callahan Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Callahan Advisors held 146 positions worth $862M, up 8.3% from $796M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Callahan Advisors's Q4 2023 filing shows 6 new, 58 increased, 58 reduced and 5 closed positions. Its largest new stake was Invesco QQQ Trust: 557 shares worth $228K. The largest sale was Skyworks Solutions, an estimated $2.76M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Callahan Advisors's largest Q4 2023 buy was Invesco QQQ Trust: 557 shares worth $228K.
  • Callahan Advisors added most to Mastercard in Q4 2023, an estimated $2.36M increase.
  • Callahan Advisors's biggest Q4 2023 reduction was Skyworks Solutions, cutting an estimated $2.76M.
  • Callahan Advisors fully exited Bristol-Myers Squibb in Q4 2023, selling an estimated $1.28M.
  • Callahan Advisors's ten largest holdings make up 34% of its $862M portfolio in Q4 2023.
  • Callahan Advisors opened 6 new positions and closed 5 in Q4 2023.
  • Callahan Advisors's portfolio value rose 8.3% quarter-over-quarter to $862M.

Based on Callahan Advisors's 13F filing for Q4 2023, filed 24 Jan 2024.